ORGANOGENESIS HOLDINGS INC. Amortization of Intangible Assets
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Amortization of Intangible Assets of $6.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for the quarter ending 2026-06-30 was $433.00K, a 48.51% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for the quarter ending 2026-03-31 was $5.71M, a 577.91% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for the quarter ending 2025-12-31 was $798.00K, a 4.32% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for the quarter ending 2025-09-30 was $842.00K, a 0.96% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for fiscal 2025 was $3.32M, a 2.35% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for fiscal 2024 was $3.40M, a 30.81% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for fiscal 2023 was $4.92M, a 0.72% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. amortization of intangible assets for fiscal 2022 was $4.88M, a 1.33% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.14M 10-Q · filed 2026-08-06 | $6.94M derived: sum of 3 quarters · filed 2026-08-06 | $7.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $5.71M 10-Q · filed 2026-05-07 | $6.51M derived: sum of 2 quarters · filed 2026-05-07 | $7.35M derived: sum of 3 quarters · filed 2026-05-07 | $8.19M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2025-12-31 | $798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.64M derived: sum of 2 quarters · filed 2026-02-26 | $2.48M derived: sum of 3 quarters · filed 2026-02-26 | $3.32M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $842.00K 10-Q · filed 2025-11-06 | $1.68M derived: sum of 2 quarters · filed 2025-11-06 | $2.52M 10-Q · filed 2025-11-06 | $3.36M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2025-06-30 | $841.00K 10-Q · filed 2025-08-07 | $1.68M 10-Q · filed 2026-08-06 | $2.52M derived: sum of 3 quarters · filed 2026-05-07 | $3.35M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2025-03-31 | $842.00K 10-Q · filed 2026-05-07 | $1.68M derived: sum of 2 quarters · filed 2026-05-07 | $2.51M derived: sum of 3 quarters · filed 2026-05-07 | $3.34M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $834.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.67M derived: sum of 2 quarters · filed 2026-02-26 | $2.50M derived: sum of 3 quarters · filed 2026-02-26 | $3.40M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $834.00K 10-Q · filed 2025-11-06 | $1.67M derived: sum of 2 quarters · filed 2025-11-06 | $2.57M 10-Q · filed 2025-11-06 | $3.80M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $834.00K 10-Q · filed 2025-08-07 | $1.74M 10-Q · filed 2025-08-07 | $2.96M derived: sum of 3 quarters · filed 2026-02-26 | $4.19M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $901.00K 10-Q · filed 2025-05-08 | $2.13M derived: sum of 2 quarters · filed 2026-02-26 | $3.36M derived: sum of 3 quarters · filed 2026-02-26 | $4.59M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.46M derived: sum of 2 quarters · filed 2026-02-26 | $3.69M derived: sum of 3 quarters · filed 2026-02-26 | $4.92M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $1.23M 10-Q · filed 2024-11-12 | $1.23M 10-Q · filed 2023-11-09 | $2.46M derived: sum of 2 quarters · filed 2024-11-12 | $3.69M 10-Q · filed 2024-11-12 | $3.69M 10-Q · filed 2023-11-09 | $4.91M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.23M 10-Q · filed 2024-08-08 | $2.46M 10-Q · filed 2024-08-08 | $3.68M derived: sum of 3 quarters · filed 2025-02-27 | $4.90M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $1.23M 10-Q · filed 2024-05-09 | $2.45M derived: sum of 2 quarters · filed 2025-02-27 | $3.67M derived: sum of 3 quarters · filed 2025-02-27 | $4.89M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.44M derived: sum of 2 quarters · filed 2025-02-27 | $3.66M derived: sum of 3 quarters · filed 2025-02-27 | $4.88M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $1.22M 10-Q · filed 2023-11-09 | $2.44M derived: sum of 2 quarters · filed 2023-11-09 | $3.66M 10-Q · filed 2023-11-09 | $4.88M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $1.22M 10-Q · filed 2023-08-09 | $2.44M 10-Q · filed 2023-08-09 | $3.67M derived: sum of 3 quarters · filed 2024-02-29 | $4.91M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $1.22M 10-Q · filed 2023-05-10 | $2.44M derived: sum of 2 quarters · filed 2024-02-29 | $3.68M derived: sum of 3 quarters · filed 2024-02-29 | $4.93M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.46M derived: sum of 2 quarters · filed 2024-02-29 | $3.71M derived: sum of 3 quarters · filed 2024-02-29 | $4.95M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $1.24M 10-Q · filed 2022-11-09 | $2.48M derived: sum of 2 quarters · filed 2022-11-09 | $3.73M 10-Q · filed 2022-11-09 | $4.95M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $1.24M 10-Q · filed 2022-08-09 | $2.49M 10-Q · filed 2022-08-09 | $3.71M derived: sum of 3 quarters · filed 2023-03-01 | $4.60M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-10 | $2.47M derived: sum of 2 quarters · filed 2023-03-01 | $3.35M derived: sum of 3 quarters · filed 2023-03-01 | $4.17M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.11M derived: sum of 2 quarters · filed 2023-03-01 | $2.93M derived: sum of 3 quarters · filed 2023-03-01 | $3.75M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $885.00K 10-Q · filed 2021-11-09 | $1.70M derived: sum of 2 quarters · filed 2021-11-09 | $2.52M 10-Q · filed 2021-11-09 | $4.04M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $816.00K 10-Q · filed 2021-08-09 | $1.63M 10-Q · filed 2021-08-09 | $3.15M derived: sum of 3 quarters · filed 2022-03-01 | $4.68M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $817.00K 10-Q · filed 2021-05-11 | $2.33M derived: sum of 2 quarters · filed 2022-03-01 | $3.86M derived: sum of 3 quarters · filed 2022-03-01 | $5.36M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.05M derived: sum of 2 quarters · filed 2022-03-01 | $4.54M derived: sum of 3 quarters · filed 2022-03-01 | $6.04M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $1.53M 10-Q · filed 2020-11-09 | $3.03M derived: sum of 2 quarters · filed 2020-11-09 | $4.53M 10-Q · filed 2020-11-09 | $5.44M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | $1.50M 10-Q · filed 2020-08-10 | $3.00M 10-Q · filed 2020-08-10 | $3.91M derived: sum of 3 quarters · filed 2021-03-16 | $4.83M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | $1.50M 10-Q · filed 2020-05-11 | $2.42M derived: sum of 2 quarters · filed 2021-03-16 | $3.33M derived: sum of 3 quarters · filed 2021-03-16 | $4.25M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.83M derived: sum of 2 quarters · filed 2021-03-16 | $2.75M derived: sum of 3 quarters · filed 2021-03-16 | $3.67M 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $918.00K 10-Q · filed 2019-11-12 | $1.83M derived: sum of 2 quarters · filed 2019-11-12 | $2.75M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $917.00K 10-Q · filed 2019-08-09 | $1.83M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $917.00K 10-Q · filed 2019-05-10 | |||||
| 2017-12-31 | $2.04M 10-K · filed 2020-03-09 | |||||
| 2016-12-31 | $1.62M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |